Current efforts in disease-modifying therapies are increasingly focused on targeting alpha-synuclein (-Syn), the hallmark protein of PD
Anecdotally, users in the recovery and biohacking space report meaningful subjective improvement in joint comfort and training tolerance, but that's self-report, not controlled data
Zarwno BPC-157, jak i TB-500 wspieraj ten proces
Antioxidant Power and Detoxification Support Your liver processes thousands of chemicals daily, and glutathione serves as its most trusted partner
The STEP 5 trial found that 92.8% of participants completed the full two-year study, indicating excellent long-term tolerability
100% achieved 5% or more, 93% achieved 10% or more, and 83% achieved 15% or more in Phase 2